However, these studies did not find significant difference between BKV DNA positive and negative SLE patients in terms of SLE disease activity index (SLEDAI) score, presence of anti-dsDNA antibodies, CD4+/CD8+ ratio, and therapy. This evidence concerns the gene CD4 and systemic lupus erythematosus.